Delivery Order SPE2DB20D3103-SPE2DB25FQ1X4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.82 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,802.16 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,992.89 to AmerisourceBergen Drug Corp for 100 tablets of OxyContin ER 40 mg, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a continuation of the vendor's pharmaceutical supply relationship with the federal government. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,924.20 for OxyContin ER 10 mg tablets (100-count) with an ultimate completion date of July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,009.06 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,208.27 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,967.11 to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price, non-set-aside contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,242.26 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (quantity: 100s) on August 29, 2025, with an ultimate completion date of September 2, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ1X4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,805.40 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, holds significant standing as a federal medical procurement vendor, particularly through its relationship with the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio of federal contract awards demonstrates capability across diverse pharmaceutical categories including specialty medications, brand-name and generic drugs, and medical supplies supporting military and veteran healthcare systems. This specific delivery order for pain management pharmaceuticals exemplifies the company's role in fulfilling critical medical supply needs for the Department of Defense, leveraging its established IDC vehicle to enable rapid procurement and delivery of essential medications to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 9/8/25 |